Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
P/S (TTM)
1.8
IsoPlexis Corporation is a life sciences company dedicated to advancing the development of novel curative treatments and personalized therapeutics. The company's innovative offerings serve a wide international market, spanning North America (United States, Canada), numerous European nations (United Kingdom, Belgium, France, Czech Republic, Spain, Germany, Sweden, Italy, Switzerland), and key Asian and Pacific regions (Israel, China, Taiwan, Singapore, Japan, Australia, Korea). At its core, IsoPlexis provides a proprietary single-cell proteomics platform. This comprehensive system integrates specialized instruments, consumable chips, and advanced software, delivering an end-to-end solution for observing protein activity and function at the individual cellular level. Its instrument lineup includes the IsoLight and IsoSpark systems. For chip consumables, it offers IsoCode chips, designed for multiplexed single-cell functional proteomics, and CodePlex chips, which provide multiplexed analysis for ultra-low volume bulk samples. The IsoSpeak software further enhances the platform, providing robust dimensional data analysis and automating workflows through an intuitive, push-button user interface. This enables rapid, same-day visualization of both single-cell and bulk proteome data. Beyond its core products, IsoPlexis also extends research support and post-warranty services. Established in 2013, the company operates from its base in Branford, Connecticut.
brukercellularanalysis.comNo one on the platform currently holds ISO.
No tracked institution reports a position in ISO as of their last filing.
No one on the platform has traded ISO yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
Beat consensus in 0 of the last 6 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2023-03-02 | $-0.39 | $-0.84 | -115.4% |
| 2022-11-10 | $-0.43 | $-0.47 | -9.3% |
| 2022-08-10 | $-0.54 | $-0.65 | -20.4% |
| 2022-05-11 | $-0.59 | $-0.74 | -25.4% |
| 2022-03-02 | $-0.68 | $-1.69 | -148.5% |
| 2021-11-10 | $-0.79 | $-10.66 | -1249.4% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| ISOIsoPlexis Corporation | $0.76 | +0.00% | $30M | — |
| ALLKAllakos Inc. | $0.33 | +0.22% | $30M | — |
| ANGNAngion Biomedica Corp. | $1.00 | +0.00% | $30M | — |
| ANPCAnPac Bio-Medical Science Co., Ltd. | $4.30 | -3.15% | $27M | — |
| ELUTElutia Inc | $0.82 | +2.50% | $36M | — |
| HEXOHEXO Corp. | $0.71 | +2.45% | $31M | — |
Source: Financial Modeling Prep · peers by sector/industry
| MRNSMarinus Pharmaceuticals, Inc. |
| $0.55 |
| +0.00% |
| $30M |
| — |
$ISO halted exploration at Larocque East and pulled most field crews as wildfires hit the Athabasca Basin. Short-term operational pause, but the bigger watch is how long the fire risk lasts and whether this slows uranium project timelines.
View on StockTwits ↗$SPY $QQQ $NVDA $AAPL $ISO No deal Pure pump and dump again
View on StockTwits ↗$ISO LOL http://oilprice.com 🤣🤣🤣 That’s the British China boy on theVirgin Islands supplying CNBC and other Iran stae media with nonsense 🤣🤣🤣🤣🤣
View on StockTwits ↗$ISO $SPY $QQQ If china says they want to buy saudi, UAE and other oil, iran would allow it $MVDA
View on StockTwits ↗$ASPI $iso:jse traded first time on the jse stock exchange . 217 rand bid which is $12.22. Tiny volume today.
View on StockTwits ↗$ISO ASP Isotopes: A Promising Isotope Enrichment Play, But Significant Risks Remain https://beyondspx.com/article/asp-isotopes-a-promising-isotope-enrichment-play-but-significant-risks-remain
View on StockTwits ↗$ANLDF $ISO exactly how I feel - I own no $ISO $ISENF but I will do my DD. On the surface they have a good amount of ownership invested among big uranium companies like $UUUU who have the know how to get the mill up and running
View on StockTwits ↗$ANLDF exchange rate for $ISO equals .105 per share. Not great not terrible. But will ride iso forward as I am sure they will have the mill operational asap and this will become a key asset to nuclear renaissance and US energy independence over the next 20 years.
View on StockTwits ↗$ISO ASP Isotopes: A Promising Isotope Enrichment Play, But Significant Risks Remain http://beyondspx.com/2024/08/05/asp-isotopes-a-promising-isotope-enrichment-play-but-significant-risks-remain/
View on StockTwits ↗Trading Channels #Uranium Update (16.04.24) https://open.substack.com/pub/tradingchannels/p/trading-channels-uranium-update-160424?r=2butt5&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true #ura #urnm #urnj $ccj $uec $yca $iso
View on StockTwits ↗Isodiol International Inc. $ISO has been making moves in the market. Any insights on its recent performance, and do you have updates on STLNF that you'd like to discuss?
View on StockTwits ↗Isodiol International Inc. ($ISO) has been making moves in the market. Any insights on its recent performance, and do you have updates on STLNF that you'd like to discuss?
View on StockTwits ↗IsoEnergy Director Richard Patricio Sells C$132,500.00 in $ISO www.marketbeat.com/stocks/CVE/ISO/insider-trades/
View on StockTwits ↗@EL20228888 I ended up with $BLI and $CELL shares from my $ISO holdings. I assume there was some hope for a drug back in the $100+ days, but I know nothing about either of these companies, and don't care to research them beyond, my quick Google search. Hope your retirement works out. :-). I will keep what I ended up with and hope for the best.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.